← 返回前沿论文

「表达 IL-15/IL-18 与 CXCR2 改善乳腺癌中靶向 EGFRvIII 的 CAR-T 细胞浸润与存活」勘误,Biochemical Pharmacology 212 (2023) 115536. PMID:37028461

英文原题:Corrigendum to "Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer" biochemical pharmacology 212 (2023) 115536. PMID:37028461.

查看英文原题

Corrigendum to "Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer" biochemical pharmacology 212 (2023) 115536. PMID:37028461.

PubMed 2023/06/27(内容时间) Biochem Pharmacol Q1 · IF 6.5(JCR 2025)

摘要

这条还没有中文摘要(正在补翻译)。 可以先展开下面的英文原文,或点最下面的「在 PubMed 查看」读原文献。

论文信息

作者
Ruixin S、Yifan L、Chuanlong W、Min Z、Hong L、Guoxiu D、Zhengyang L、Yansha S
第一作者单位
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China; Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.China
通讯作者单位
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China; CARsgen Therapeutics, Shanghai 200032, China. Electronic address: zonghaili@shsmu.edu.cn.China
文献类型
勘误
期刊
Biochemical pharmacology2023 Aug
原文标识
PubMed 37384959 · DOI 10.1016/j.bcp.2023.115649